A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy - Concepedia

Concepedia

Publication | Open Access

A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy

DOI Full Paper Access

1K

Citations

39

References

2002

Year

Clemens A. Schmitt, Jordan S. Fridman, Meng Yang, Soyoung Lee, Eugene Baranov, Robert M. Hoffman, Scott W. Lowe

Cancer TherapyLifespan ExtensionAgingMedicineP16ink4a ContributesCellular SenescenceSenescence ProgramTumor SuppressorCancer TreatmentRadiation OncologyOncologyCell BiologyCancer ResearchTumor Biology

References

	Year	Citations

Page 1

Page 1